The humble henna plant, famed for its vibrant dye, could hold the key to healing scarred livers. In a new study, researchers have found that its active compound, lawsone, may stop and even reverse ...

Long-term acid blockade medication use among children and adolescents with cystic fibrosis produces only minimal improvements in weight and BMI.

Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Spiritual leader Premanand Maharaj is reportedly battling polycystic kidney disease (PKD), a genetic disorder causing cysts to grow in his kidneys, le ...

These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...

Discover a study exploring NOD1 and key genes in HBV-related acute liver failure, revealing insights for diagnosis and ...

Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians ...

If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis ...

Pro Football Hall of Famer and Miami Dolphins legend Dan Marino had a wake-up call in 2007 when he received a personal health diagnosis. Now, he’s sharing his journey to help others who may be ...

THE AVAILABILITY of elexacaftor–tezacaftor–ivacaftor (ETI) has been associated with a marked reduction in cystic fibrosis liver disease (CFLD) progression, according to a nationwide analysis.